Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1

Molecular Biology of the Cell

Volumn 19, Issue 9, 2008, Pages 3667-3675

  Klein, Alexandra ^a   Flügel, Daniela ^a   Kietzmann, Thomas ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; HYPOXIA INDUCIBLE FACTOR 1; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE 2; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANOXIA; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN; PROCOLLAGEN-PROLINE DIOXYGENASE; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 55549083185     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-01-0042     Document Type: Article

References (64)

1. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D., and Pouyssegur, J. (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steadystate levels of HIF-1alpha in normoxia. EMBO J. 22, 4082-4090.
2. Bischoff, J. R. et al. (1998). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052-3065.
3. Bonello, S., Zahringer, C., BelAiba, R. S., Djordjevic, T., Hess, J., Michiels, C., Kietzmann, T., and Görlach, A. (2007). Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler. Thromb. Vasc. Biol. 27, 755-761.
4. Brahimi-Horn, C., and Pouyssegur, J. (2006). The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull. Cancer 93, E73-E80.
5. Brown, J. M. (2002). Tumor microenvironment and the response to anticancer therapy. Cancer Biol. Ther. 1, 453-458.
6. Bruick, R. K., and McKnight, S. L. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
7. Collonge-Rame, M. A., Bresson-Hadni, S., Koch, S., Carbillet, J. P., Blagosklonova, O., Mantion, G., Miguet, J. P., Heyd, B., and Bresson, J. L. (2001). Pattern of chromosomal imbalances in non-B virus related hepatocellular carcinoma detected by comparative genomic hybridization. Cancer Genet. Cytogenet. 127, 49-52.
8. Dimova, E. Y., and Kietzmann, T. (2006). Cell type-dependent regulation of the hypoxia-responsive plasminogen activator inhibitor-1 gene by upstream stimulatory factor-2. J. Biol. Chem. 281, 2999-3005.
9. Dimova, E. Y., Moller, U., Herzig, S., Fink, T., Zachar, V., Ebbesen, P., and Kietzmann, T. (2005). Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells. Thromb. Haemost. 93, 1176-1184.
10. Du, J., and Hannon, G. J. (2002). The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. Nucleic Acids Res. 30, 5465-5475.
11. Du, J., and Hannon, G. J. (2004). Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion. Proc. Natl. Acad. Sci. USA 101, 8975-8980.
12. Epstein, A. C. et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
13. Flügel, D., Görlach, A., Michiels, C., and Kietzmann, T. (2007). Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol. Cell. Biol. 27, 3253-3265.
14. Fraizer, G. C., Diaz, M. F., Lee, I. L., Grossman, H. B., and Sen, S. (2004). Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int. J. Oncol. 25, 1631-1639.
15. Giatromanolaki, A., and Harris, A. L. (2001). Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res. 21, 4317-4324.
16. Giet, R., Petretti, C., and Prigent, C. (2005). Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol. 15, 241-250.
17. Hewitson, K. S. et al. (2002). Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355.
18. Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252, 954-958.
19. Hon, W. C., Wilson, M. I., Harlos, K., Claridge, T. D., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., and Jones, E. Y. (2002). Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 417, 975-978.
20. Immenschuh, S., Hinke, V., Ohlmann, A., Gifhorn-Katz, S., Katz, N., Jungermann, K., and Kietzmann, T. (1998b). Transcriptional activation of the heme oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes. Biochem. J. 334, 141-146.
21. Ivan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Gunzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., and Kaelin, W. G., Jr. (2002). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99, 13459-13464.
22. 2 sensing. Science 292, 464-468.
23. Jaakkola, P. et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O-2-regulated prolyl hydroxylation. Science 292, 468-472.
24. Jeng, Y. M., Peng, S. Y., Lin, C. Y., and Hsu, H. C. (2004). Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin. Cancer Res. 10, 2065-2071.
25. Kaelin, W. G., Jr., and Maher, E. R. (1998). The VHL tumour-suppressor gene paradigm. Trends Genet. 14, 423-426.
26. Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., and Poellinger, L. (1999). Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525.
27. Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W. G., Jr. Conaway, R. C., and Conaway, J. W. (1998). The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12, 3872-3881.
28. Katayama, H., Ota, T., Jisaki, F., Ueda, Y., Tanaka, T., Odashima, S., Suzuki, F., Terada, Y., and Tatsuka, M. (1999). Mitotic kinase expression and colorectal cancer progression. J. Natl. Cancer Inst. 91, 1160-1162.
29. Katayama, H., Zhou, H., Li, Q., Tatsuka, M., and Sen, S. (2001). Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle. J. Biol. Chem. 276, 46219-46224.
30. Kietzmann, T., Cornesse, Y., Brechtel, K., Modaressi, S., and Jungermann, K. (2001). Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver. Biochem. J. 354, 531-537.
31. Kietzmann, T., and Görlach, A. (2005). Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin. Cell Dev. Biol. 16, 474-486.
32. Kietzmann, T., Roth, U., and Jungermann, K. (1999). Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia inducible factor-1 in rat hepatocytes. Blood 94, 4177-4185.
33. Kim, G. J., Cho, S. J., Won, N. H., Sung, J. M., Kim, H., Chun, Y. H., and Park, S. H. (2003). Genomic imbalances in Korean hepatocellular carcinoma. Cancer Genet. Cytogenet. 142, 129-133.
34. Klein, A., Jung, V., Zang, K. D., Henn, W., Montenarh, M., Kartarius, S., Steudel, W. I., and Urbschat, S. (2005). Detailed chromosomal characterization of the breast cancer cell line MCF7 with special focus on the expression of the serine-threonine kinase 15. Oncol. Rep. 14, 23-31.
35. Klein, A., Reichardt, W., Jung, V., Zang, K. D., Meese, E., and Urbschat, S. (2004). Overexpression and amplification of STK15 in human gliomas. Int. J. Oncol. 25, 1789-1794.
36. Koivunen, P., Tiainen, P., Hyvarinen, J., Williams, K. E., Sormunen, R., Klaus, S. J., Kivirikko, K. I., and Myllyharju, J. (2007). An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha. J. Biol. Chem. 282, 30544-30552.
37. Kufer, T. A., Sillje, H. H., Korner, R., Gruss, O. J., Meraldi, P., and Nigg, E. A. (2002). Human TPX2 is required for targeting Aurora-A kinase to the spindle. J. Cell Biol. 158, 617-623.
38. Landen, C. N., Jr., Lin, Y. G., Immaneni, A., Deavers, M. T., Merritt, W. M., Spannuth, W. A., Bodurka, D. C., Gershenson, D. M., Brinkley, W. R., and Sood, A. K. (2007). Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients. Clin. Cancer Res. 13, 4098-4104.
39. Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., and Bruick, R. K. (2002a). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
40. Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., and Whitelaw, M. L. (2002b). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861.
41. Mahon, P. C., Hirota, K., and Semenza, G. L. (2001). FIH-1, a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686.
42. Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G., and Semenza, G. L. (2005). Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105, 659-669.
43. Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., and Ratcliffe, P. J. (2001). Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206.
44. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe, P. J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
45. Min, J. H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., Jr., and Pavletich, N. P. (2002). Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889.
46. Miyoshi, Y., Iwao, K., Egawa, C., and Noguchi, S. (2001). Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int. J. Cancer 92, 370-373.
47. Niketeghad, F., Decker, H. J., Caselmann, W. H., Lund, P., Geissler, F., Dienes, H. P., and Schirmacher, P. (2001). Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br. J. Cancer 85, 697-704.
48. Oehme, F., Ellinghaus, P., Kolkhof, P., Smith, T. J., Ramakrishnan, S., Hutter, J., Schramm, M., and Flamme, I. (2002). Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296, 343-349.
49. Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T. Y., Huang, L. E., Pavletich, N., Chau, V., and Kaelin, W. G., Jr. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427.
50. Petry, A., Djordjevic, T., Weitnauer, M., Kietzmann, T., Hess, J., and Görlach, A. (2006). NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid. Redox. Signal. 8, 1473-1484.
51. Reichardt, W., Jung, V., Brunner, C., Klein, A., Wemmert, S., Romeike, B. F., Zang, K. D., and Urbschat, S. (2003). The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Oncol. Rep. 10, 1275-1279.
52. Safran, M., and Kaelin, W. G., Jr. (2003). HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Invest. 111, 779-783.
53. Sakakura, C., Hagiwara, A., Yasuoka, R., Fujita, Y., Nakanishi, M., Masuda, K., Shimomura, K., Nakamura, Y., Inazawa, J., Abe, T., and Yamagishi, H. (2001). Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer 84, 824-831.
54. Salceda, S., and Caro, J. (1997). Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647.
55. Scharf, J. G., Unterman, T. G., and Kietzmann, T. (2005). Oxygen-dependent modulation of IGF binding protein biosynthesis in primary cultures of rat hepatocytes. Endocrinology 146, 5433-5443.
56. Semenza, G. L. (2002). HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8, S62-S67.
57. Sen, S., Zhou, H., and White, R. A. (1997). A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14, 2195-2200.
58. Tanaka, M., Ueda, A., Kanamori, H., Ideguchi, H., Yang, J., Kitajima, S., and Ishigatsubo, Y. (2002). Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J. Biol. Chem. 277, 10719-10726.
59. Tanaka, T., Kimura, M., Matsunaga, K., Fukada, D., Mori, H., and Okano, Y. (1999). Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 59, 2041-2044.
60. Tanimoto, K., Makino, Y., Pereira, T., and Poellinger, L. (2000). Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19, 4298-4309.
61. Udayakumar, T. S., Belakavadi, M., Choi, K. H., Pandey, P. K., and Fondell, J. D. (2006). Regulation of Aurora-A kinase gene expression via GABP recruitment of TRAP220/MED1. J. Biol. Chem. 281, 14691-14699.
62. 2-regulated gene expression. FASEB J. 16, 1151-1162.
63. Wenger, R. H., Stiehl, D. P., and Camenisch, G. (2005). Integration of oxygen signaling at the consensus HRE. Sci. STKE. 2005, re12.
64. Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W., Sahin, A., Brinkley, B. R., and Sen, S. (1998). Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20, 189-193.